Cargando…

Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis

Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Patnaik, Rupali, Azim, Afzal, Mishra, Prabhaker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022053/
https://www.ncbi.nlm.nih.gov/pubmed/33840923
http://dx.doi.org/10.4103/joacp.JOACP_388_19
_version_ 1783674865058840576
author Patnaik, Rupali
Azim, Afzal
Mishra, Prabhaker
author_facet Patnaik, Rupali
Azim, Afzal
Mishra, Prabhaker
author_sort Patnaik, Rupali
collection PubMed
description Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrations and PCT non-clearance are associated with poor outcomes in patients with sepsis and some studies have cited as having no additional benefit. Most of the studies have evaluated single PCT measurement and correlated with prognosis and outcome in septic patients. Limited literature is there about serial PCT levels and its impact on the outcome of patients with sepsis. We searched literature through PubMed, Embase, Web of Knowledge, and the Cochrane Library from 2007 to 2017 and present a systematic review and meta-analysis of studies evaluating the utility of serial measurement of PCT for prognosis in critically ill patients. Articles that assessed PCT non-clearance as a marker of mortality data were included. The primary objective of this meta-analysis was to pool the results of all the available studies on serial PCT non-clearance as a mortality predictor and formulate overall area under receiver operating curve (AUROC). To find out the overall proportion of mortality in PCT non-clearance was our secondary objective. To detect the mortality using PCT non-clearance, ROC curve analysis was done. Area under curve (AUC) of the studies was varying between 0.52 and 0.86. Overall AUC was observed 0.711 (95% confidence interval (CI): 0.662–0.760) under fixed effect model and 0.708 (95% CI: 0.648–0.769) under random effect model. There was moderate variation among the studies, i.e., I(2) 50.80% (95% CI: 0.00–80.42%). The overall proportion of mortality was 37.54% with much heterogeneity (I(2) 88.24%) among the studies. PCT non-clearance is a fair predictor of mortality. Further studies are needed to define optimal cut off point for PCT non-clearance in ICU patients with sepsis.
format Online
Article
Text
id pubmed-8022053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80220532021-04-08 Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis Patnaik, Rupali Azim, Afzal Mishra, Prabhaker J Anaesthesiol Clin Pharmacol Review Article Sepsis is a life-threatening condition with dysregulated host response to infection. It is a major determinant of mortality in the intensive care unit (ICU). Procalcitonin (PCT) is widely investigated for prognosis in patients with sepsis. Most of the studies have cited that elevated PCT concentrations and PCT non-clearance are associated with poor outcomes in patients with sepsis and some studies have cited as having no additional benefit. Most of the studies have evaluated single PCT measurement and correlated with prognosis and outcome in septic patients. Limited literature is there about serial PCT levels and its impact on the outcome of patients with sepsis. We searched literature through PubMed, Embase, Web of Knowledge, and the Cochrane Library from 2007 to 2017 and present a systematic review and meta-analysis of studies evaluating the utility of serial measurement of PCT for prognosis in critically ill patients. Articles that assessed PCT non-clearance as a marker of mortality data were included. The primary objective of this meta-analysis was to pool the results of all the available studies on serial PCT non-clearance as a mortality predictor and formulate overall area under receiver operating curve (AUROC). To find out the overall proportion of mortality in PCT non-clearance was our secondary objective. To detect the mortality using PCT non-clearance, ROC curve analysis was done. Area under curve (AUC) of the studies was varying between 0.52 and 0.86. Overall AUC was observed 0.711 (95% confidence interval (CI): 0.662–0.760) under fixed effect model and 0.708 (95% CI: 0.648–0.769) under random effect model. There was moderate variation among the studies, i.e., I(2) 50.80% (95% CI: 0.00–80.42%). The overall proportion of mortality was 37.54% with much heterogeneity (I(2) 88.24%) among the studies. PCT non-clearance is a fair predictor of mortality. Further studies are needed to define optimal cut off point for PCT non-clearance in ICU patients with sepsis. Wolters Kluwer - Medknow 2020 2021-01-18 /pmc/articles/PMC8022053/ /pubmed/33840923 http://dx.doi.org/10.4103/joacp.JOACP_388_19 Text en Copyright: © 2021 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Patnaik, Rupali
Azim, Afzal
Mishra, Prabhaker
Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title_full Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title_fullStr Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title_full_unstemmed Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title_short Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis
title_sort should serial monitoring of procalcitonin be done routinely in critically ill patients of icu: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022053/
https://www.ncbi.nlm.nih.gov/pubmed/33840923
http://dx.doi.org/10.4103/joacp.JOACP_388_19
work_keys_str_mv AT patnaikrupali shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis
AT azimafzal shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis
AT mishraprabhaker shouldserialmonitoringofprocalcitoninbedoneroutinelyincriticallyillpatientsoficuasystematicreviewandmetaanalysis